Has Jonathan Danoff, MD received payments from drug or device companies?

Yes. Drug and device makers reported $180,610 in general payments to Jonathan Danoff, MD across 219 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Danoff, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Danoff, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Danoff, MD

Adult Reconstructive Orthopaedic Surgery · Great Neck, NYNPI 1689973091

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $127,531 of the $180,610 with a category attached, or 70.6%. Stryker accounts for 67.9% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $92,530, more than ten times the $2,593 reported in 2019.

$180,610in general payments, 2019–2025

Across 219 payments — averaging $824.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$123K
Sanara Medtech Inc.$23K
Think Surgical, Inc.$13K
Pacira Therapeutics, Inc.$11K
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$4K
Acelrx Pharmaceuticals, Inc.$2K
plus $4K from 4 others

$131,863in research payments, 2019–2025

Across 12 payments — averaging $10,989 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$132K

What the payments were for

Consulting fees$127,53171%
Speaking & faculty fees$26,60615%
Travel & lodging$16,5039%
Food & beverage$9,9706%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker(2 entities)	165	$122,632
Sanara Medtech Inc.	8	$23,230
Think Surgical, Inc.	6	$12,878
Pacira Therapeutics, Inc.	8	$11,136
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)	2	$4,450
Acelrx Pharmaceuticals, Inc.	1	$2,000
Zimmer Biomet	18	$1,940
Globus Medical	9	$1,935
Encore Medical, LP	1	$230
Orthalign Inc	1	$178

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$105,273
CellerateRx$22,619
INSIGNIA$21,538
TMINI Miniature Robotic System$12,878
TRIATHLON$12,688
Zilretta$11,136
ACCOLADE$2,964
TRIDENT$2,550
RESTORATION$2,550
Surgical wound closure product$2,400
DSUVIA$2,000
X3$1,275
RESTORIS$1,275
GMRS$1,275
ACTIFY 3D$1,230
Biasurge$588
ROSA$406
Persona$288
mymobility Platform$249
G7$232

How this compares

$180,610 in reported general payments places this provider in the 85th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$1,073,951

Medicare patients

1,278

Services billed

11,313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	216	$4,144
Meloxicam	766	$2,490
Naproxen	49	$249
Diclofenac Sodium	27	$212
Oxycodone Hcl	29	$170
Methylprednisolone	17	$138
Tramadol Hcl	13	$51

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Great Neck

Paul EnkerGreat Neck$5K
Seth JerabekNew York$7.1M
Jose RodriguezNew York$3.4M
Friedrich BoettnerNew York$2.9M
Jonathan VigdorchikNew York$2.3M
William LongNew York$1.5M
Peter SculcoNew York$1.5M
Roshan ShahNew York$1.3M
Herbert CooperNew York$1.3M
Matthew AustinNew York$986K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →